San Antonio—Dexmedetomidine offers several important advantages for weaning patients off mechanical ventilation in the ICU. But whether the drug is a clear-cut front-runner for these patients—particularly the 15% who prove resistant to such weaning—needs further study, Gilles L. Fraser, PharmD, MCCM, noted during the 2018 annual congress of the Society of Critical Care Medicine (SCCM).
Dexmedetomidine offers theoretical advantages in this setting, said Dr. Fraser, a critical